CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of KCNK13 inhibitors for neurodegenerative diseases characterized by neuroinflam ...

"This launch represents a major expansion of our professional learning portfolio, enabling us to provide even more impactful ...

CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of ...